Wealthspire Advisors (New York)’s KORU Medical Systems KRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92.6K Buy
21,425
+1,000
+5% +$4.96K ﹤0.01% 896
2025
Q4
$119K Hold
20,425
﹤0.01% 995
2025
Q3
$78.2K Buy
+20,425
New +$78.1K ﹤0.01% 1090

Other funds holding KRMD

Wealthspire Advisors (New York)'s KRMD Position: Q1 2026 in Review

Wealthspire Advisors (New York) increased its KORU Medical Systems (KRMD) stake by 4.9% in Q1 2026, buying an estimated $4.96K and bringing the position to 21,425 shares worth $92.6K. The position accounts for ﹤0.01% of the portfolio, ranked #896.

Wealthspire Advisors (New York) first reported a position in KRMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $119K in Q4 2025. 91 funds tracked by Wall St. Rank hold KRMD as of Q1 2026.

  • Wealthspire Advisors (New York) held 21,425 shares of KORU Medical Systems worth $92.6K as of Q1 2026.
  • Wealthspire Advisors (New York) bought 1,000 KORU Medical Systems shares in Q1 2026, an estimated $4.96K.
  • KORU Medical Systems made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #896 holding.
  • Wealthspire Advisors (New York) first reported a position in KORU Medical Systems in Q3 2025 and has held it in 3 quarters since.
  • Wealthspire Advisors (New York)'s KORU Medical Systems position peaked at $119K in Q4 2025.
  • 91 funds tracked by Wall St. Rank held KORU Medical Systems as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.